FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential
Read moreThe FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential
Read moreEvusheld was a key antibody treatment taken by people with weak immune systems as an added layer of protection. Source
Read morePersonal medical devices for conditions such as diabetes and sleep apnea are connecting to the internet, introducing privacy, hacking and
Read moreHOUSTON, Texas Nearly 3,600 cases of monkeypox have been reported in the US as of Tuesday, with at least one
Read moreWASHINGTON The US Food and Drug Administration (FDA) approved on Friday Moderna and Pfizer-BioNtech COVID-19 shots for children as young
Read more